A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis (CARES)
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
GlaxoSmithKline
Alexion Pharmaceuticals, Inc.
Kedrion S.p.A.
Life Molecular Imaging SA
Attralus, Inc.
Nexcella Inc.
Nanjing IASO Biotechnology Co., Ltd.
Sanofi
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc.
K-Group Alpha, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc.
Attralus, Inc.
Prothena Biosciences Ltd.
Attralus, Inc.
Oncopeptides AB
GlaxoSmithKline
Prothena Biosciences Ltd.
Prothena Biosciences Ltd.
Prothena Biosciences Ltd.
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline
INSYS Therapeutics Inc